- Presentations
- 3
- Markets
- 1
Renvela is a brand of Sevelamer marketed by Genzyme, with 3 presentations listed and registered in United States. Each presentation below has its own page with packs, documents and availability for export supply from India.
- Active ingredient (INN)
- Sevelamer
- Brand owner
- Genzyme
- Registered in
- United States
- Strengths and forms
- 2400 mg powder for oral suspension, 800 mg powder for oral suspension, 800 mg tablet
All presentations
| Medicine | Manufacturer | Register | Availability |
|---|---|---|---|
| Renvela 2400 mg powder for oral suspensionOral | Genzyme | US FDA | Available on request |
| Renvela 800 mg powder for oral suspensionOral | Genzyme | US FDA | Available on request |
| Renvela 800 mg tabletOral | Genzyme | US FDA | Available on request |
Brand names and trademarks belong to their owners and are used only to identify products.
Request Renvela
Send one request with the destination country and quantity. We confirm availability, lead time and the documents your regulator needs.